{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:41:41Z","timestamp":1760370101190,"version":"3.41.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Regional Institute of Medical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among hospitalized children aged between 1 and 12\u2009years. A cross-sectional study was conducted to determine the seroprevalence of SARS-CoV-2 antibodies among hospitalized children at a tertiary care hospital in the North-East region of India for a period of 13\u2009months (October 2022\u2013November 2023). The presence of SARS-CoV-2 antibodies was estimated using enzyme-linked immunosorbent assay method. Sociodemographic characteristics and clinical profile of the participants were analyzed. The seroprevalence of SARS-CoV-2 infection among hospitalized children aged between 1 and 12\u2009years was estimated to be 98.4%. This was comparable for children between the age groups 1\u20135\u2009years (97.9%) and 6\u201312\u2009years (99.1%) (P-value\u2009=\u2009.478). The most commonly reported symptoms among the seropositive children were fever (76.8%), nasal stuffiness (69.5%), cough (67.8%), diarrhea (23.6%), and nausea\/vomiting (23.2%). None of the study participants had a prior history of laboratory confirmed coronavirus disease (COVID-19) infection in the past and none were vaccinated against COVID-19. Results of the univariate analysis showed that there was no significant difference between the seropositive and seronegative children in the distribution of sociodemographic characteristics, clinical profile, and laboratory findings. Our study observed a remarkably high anti-SARS-CoV-2 seropositivity rate of 98.4%, suggesting a significant under-recognized burden of COVID-19 in the pediatric population. The findings highlight the need for continued preventive measures and the development of age-appropriate vaccination strategies, particularly in tropical settings.<\/jats:p>","DOI":"10.1093\/tropej\/fmaf007","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:18:15Z","timestamp":1738325895000},"source":"Crossref","is-referenced-by-count":1,"title":["Seroprevalence of SARS-CoV-2 infection among hospitalized children at a tertiary care center in North-East India"],"prefix":"10.1093","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7146-621X","authenticated-orcid":false,"given":"Chabungbam","family":"Smilie","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Regional Institute of Medical Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareet Kumari","family":"Nandeibam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shija Academy of Health Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongtham Shyamsunder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Regional Institute of Medical Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khuraijam Ranjana","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Regional Institute of Medical Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yendrembam Bidyalakshmi","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Regional Institute of Medical Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumlembam Bishwabati","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Shija Academy of Health Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngamba","family":"Akham","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Shija Academy of Health Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareet Laxmi","family":"Nandeibam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Regional Institute of Medical Sciences , 795004 Imphal, Manipur,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"year":"2024","author":"World Health Organization (WHO)","key":"2025030420303406900_fmaf007-B1"},{"year":"2020","key":"2025030420303406900_fmaf007-B2"},{"author":"World Health Organization (WHO)","key":"2025030420303406900_fmaf007-B3"},{"key":"2025030420303406900_fmaf007-B4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jmv.26398","article-title":"A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19)","volume":"93","author":"Cui","year":"2021","journal-title":"J Med Virol"},{"key":"2025030420303406900_fmaf007-B5","first-page":"27","article-title":"4th National Sero Survey of India: vaccine generated antibodies enhancement","volume":"4","author":"Shervani","year":"2022","journal-title":"EJMED"},{"key":"2025030420303406900_fmaf007-B6","doi-asserted-by":"crossref","first-page":"101786","DOI":"10.1016\/j.eclinm.2022.101786","article-title":"SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis","volume":"56","author":"Naeimi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025030420303406900_fmaf007-B7","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4103\/jfmpc.jfmpc_23_22","article-title":"School reopening: back to classroom. A systematic review of strategies and their implementation during COVID-19 pandemic","volume":"11","author":"Dewan","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"2025030420303406900_fmaf007-B8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10875-022-01355-w","article-title":"Long-term antibody response to SARS-CoV-2 in children","volume":"43","author":"Dunay","year":"2023","journal-title":"J Clin Immunol"},{"author":"Ministry of Health and Family Welfare (MOHFW)","key":"2025030420303406900_fmaf007-B9"},{"year":"2022","author":"BBC","key":"2025030420303406900_fmaf007-B10"},{"year":"2022","author":"Reuters","key":"2025030420303406900_fmaf007-B11"},{"key":"2025030420303406900_fmaf007-B12","doi-asserted-by":"crossref","first-page":"E 002165","DOI":"10.1136\/bmjpo-2023-002165","article-title":"Healthcare provider perspectives on COVID-19 vaccination for children in India","volume":"7","author":"Mehta","year":"2023","journal-title":"BMJPO"},{"key":"2025030420303406900_fmaf007-B13","first-page":"020706","article-title":"Seroprevalence of SARS-CoV-2 infection among children in children\u2019s hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia","volume":"31","author":"Lenicek","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"key":"2025030420303406900_fmaf007-B14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamapediatrics.2021.0001","article-title":"Prevalence of SARS-CoV-2 infection in children and their parents in southwest Germany","volume":"175","author":"T\u00f6nshoff","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2025030420303406900_fmaf007-B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijid.2021.04.086","article-title":"Prevalence of COVID-19 in children, adolescents and adults in remote education situations in the city of Fortaleza, Brazil","volume":"108","author":"Cavalcante","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2025030420303406900_fmaf007-B16","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.3390\/jcm11133819","article-title":"The seroprevalence of SARS-CoV-2 IgG antibodies in children hospitalized for reasons other than COVID-19","volume":"11","author":"Franczak","year":"2022","journal-title":"J Clin Med"},{"year":"2024","author":"The Quint","key":"2025030420303406900_fmaf007-B17"},{"key":"2025030420303406900_fmaf007-B18","doi-asserted-by":"crossref","first-page":"E 100929","DOI":"10.1016\/j.nmni.2021.100929","article-title":"Genetic emergence of B.1.617.2 in COVID-19","volume":"43","author":"Kirola","year":"2021","journal-title":"New Microbes New Infect"},{"key":"2025030420303406900_fmaf007-B19","doi-asserted-by":"crossref","first-page":"103414","DOI":"10.1016\/j.amsu.2022.103414","article-title":"Third wave in India and an update on vaccination: a short communication","volume":"75","author":"Baig","year":"2022","journal-title":"Ann Med Surg"},{"key":"2025030420303406900_fmaf007-B20","doi-asserted-by":"crossref","first-page":"E 28829","DOI":"10.1002\/jmv.28829","article-title":"SARS-CoV-2 XBB.1.16 variant: India in focus?","volume":"95","author":"Varghese","year":"2023","journal-title":"J Med Virol"},{"key":"2025030420303406900_fmaf007-B21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/archdischild-2020-320558","article-title":"Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study","volume":"106","author":"Waterfield","year":"2021","journal-title":"Arch Dis Child"},{"key":"2025030420303406900_fmaf007-B22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2025030420303406900_fmaf007-B23","doi-asserted-by":"crossref","first-page":"E 0259823","DOI":"10.1371\/journal.pone.0259823","article-title":"A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States","volume":"16","author":"Levorson","year":"2021","journal-title":"PLoS One"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/71\/2\/fmaf007\/61945720\/fmaf007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/71\/2\/fmaf007\/61945720\/fmaf007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:36:37Z","timestamp":1741124197000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmaf007\/8020908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmaf007","relation":{},"ISSN":["1465-3664"],"issn-type":[{"type":"electronic","value":"1465-3664"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,5]]},"article-number":"fmaf007"}}